CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 47,837 shares at $49.78 ($2,381,326)
- 4 Planned sale Director sold 14,514 shares at $49.63 ($720,373)
- 4 Open-market sale General Counsel and Secretary sold 1,040 shares at $49.26 ($51,230)
- 4 Open-market sale Chief Executive Officer sold 4,098 shares at $49.26 ($201,867)
- 4 Planned sale General Counsel and Secretary sold 1,990 shares at $60.04 ($119,481)
- 4 Planned sale General Counsel and Secretary sold 10,400 shares at $60.24 ($626,460)
- 4 Open-market sale Director sold 13,679 shares at $57.09 ($780,935)
- 4 Other acquisition Director acquired 75 shares (other)
- 4 Gift Chief Financial Officer gave 750 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 26 · 502 filings